Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?
The Motley Fool ·
Novo Nordisk is looking to build a volume-driven business, but the successful launch of the Wegovy pill is just the first step.
Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?
Novo Nordisk is looking to build a volume-driven business, but the successful launch of the Wegovy pill is just the first step.
1 sources · 1 articles · updated 2026-11-08 20:15 UTC · business